Trial Profile
The (cost)effectiveness of paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary) ; Alfacalcidol
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Acronyms CEPS
- 09 Aug 2011 New trial record